CASP3 and cancer: We identified proteasome inhibitors (MG-132), COX-2 inhibitor (OSU-03012), CASP3 agonists, and an inhibitor of IGF-1R (GSK-1904529A) that targeted genes identified from gene deletion analysis of personalized metabolic networks of cancer samples.